GCG and Dravet syndrome: With regards to potential molecular/cellular mechanisms, we found that GLP-1 (9-36) treatment decreased the DS-associated elevated mitochondrial superoxide, a major ROS that is linked to memory impairments and synaptic failure (Massaad and Klann, 2011; Guo et al., 2017).